Researchers found lowering TPPP3 may make ovarian cancer more sensitive to cisplatin, improving chemotherapy’s effectiveness.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting ...

A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These "persister" cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers scientists' expertise to find viable target antigens for CAR T cell ...

Immunotherapies – treatments that aim to make the body's natural immune system more effective – are becoming more widely used ...

A discovery by the Transformation and Metastasis Group of the Spanish National Cancer Research Center (CNIO) opens a path towards identifying precancerous breast lesions that will develop into tumors.

Colorectal cancer (CRC) is a leading cause of cancer-related mortality, necessitating the development of novel therapeutic strategies. In the present study, we identified TP53-regulating kinase ...

Targeted therapies show promising initial responses in non-small-cell lung cancer (NSCLC) with actionable genetic alterations; however, these responses are often incomplete and temporary 1.

You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than ...